As of December 2024, Supernus Pharmaceuticals has a market cap of $1.94B. This makes Supernus Pharmaceuticals the world's 5153th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.53B | -2.97% |
2023 | $1.58B | -18.87% |
2022 | $1.95B | 22.33% |
2021 | $1.59B | 15.90% |
2020 | $1.37B | 6.07% |
2019 | $1.30B | -28.60% |
2018 | $1.81B | -16.64% |
2017 | $2.18B | 57.82% |
2016 | $1.38B | 87.87% |
2015 | $734.26M | 61.93% |
2014 | $453.45M | 10.08% |
2013 | $411.93M | 5.16% |
2012 | $391.72M | - |